Skip to main content

Articles

Page 10 of 12

  1. Decision-analytic modelling (DAM) has become a widespread method in health technology assessments (HTA), but the extent to which modelling is used differs among international HTA institutions. In Germany, the ...

    Authors: Alexander Kuhlmann, Marina Treskova, Sebastian Braun and J-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2015 5:7
  2. Heavy episodic (“binge”) drinking of alcohol has serious public health implications, especially for youth and young adults. Previous summaries and surveys have failed to address in a comprehensive manner the e...

    Authors: Jon P Nelson
    Citation: Health Economics Review 2015 5:6

    The Letter to Editor to this article has been published in Health Economics Review 2016 6:4

  3. Recently, Nigeria emerged as the largest economy in Africa and the 26th in the world. However, a pertinent question is how this new economic status has impacted on the wealth and health of her citizens. There ...

    Authors: Adeniyi F Fagbamigbe, Elijah A Bamgboye, Bidemi O Yusuf, Joshua O Akinyemi, Bolakale K Issa, Evelyn Ngige, Perpetua Amida, Adebobola Bashorun and Emmanuel Abatta
    Citation: Health Economics Review 2015 5:5
  4. The medical record is a repository of clinical data, which can greatly enhance the quality of health and healthcare analysis. Administrative data are collected for the purpose of billing and reimbursement, and...

    Authors: David Rowell, Louisa G Gordon, Catherine M Olsen and David C Whiteman
    Citation: Health Economics Review 2015 5:4
  5. South-East Asian Regional (SEAR) countries range from low- to middle-income countries and have considerable differences in mix of public and private sector expenditure on health. This study intends to estimate...

    Authors: Jahangir AM Khan and Rashidul Alam Mahumud
    Citation: Health Economics Review 2015 5:3
  6. This article aims to assess the relationship between the monetary value of informal care - approximated with the caregiver's willingness to pay to reduce caregiving time - and the caregiver's need of three typ...

    Authors: Chloé Gervès-Pinquié, Martine M Bellanger and Joel Ankri
    Citation: Health Economics Review 2014 4:34
  7. Early benefit assessment in Germany under the legislative framework of AMNOG (Arzneimittelmarktneuordnungsgesetz) requires direct comparisons of the new drug with appropriate comparators determined by the Federal...

    Authors: Andrea Lebioda, David Gasche, Franz-Werner Dippel, Karlheinz Theobald and Stefan Plantör
    Citation: Health Economics Review 2014 4:31
  8. To obtain detailed real-world data on persistence and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in rheumatoid arthritis (RA) patients treated in Germany.

    Authors: Sarah Neubauer, Mary Cifaldi, Thomas Mittendorf, Arijit Ganguli, Malte Wolff and Jan Zeidler
    Citation: Health Economics Review 2014 4:32
  9. EQ-5D-3L valuation studies continue to employ the MVH protocol or variants of MVH. One issue that has received attention is the selection of the states for direct valuation by respondents. Changes in the valua...

    Authors: Henry Bailey, Paul Kind and Althea La Foucade
    Citation: Health Economics Review 2014 4:29
  10. Diabetes Mellitus Type II (T2DM) is a major and growing medical, social and economic burden in the East-Asian country of Cambodia. However, no economic modelling has been done to predict the number of cases an...

    Authors: Steffen Flessa and Anika Zembok
    Citation: Health Economics Review 2014 4:24
  11. The aim of this study is to estimate the cost of care and treatment for extremely low birth weight (ELBW) neonates admitted to a teaching and referral hospital. This cost estimation project can help health pol...

    Authors: Hosein Dalili, Mohaddese Fallahi, Saeid Moradi, Fatemeh Nayeri, Mamak Shariat and Arash Rashidian
    Citation: Health Economics Review 2014 4:21
  12. The introduction of the European Working Time Directive (EWTD) has greatly reduced training hours of surgical residents, which translates into 30% less surgical and clinical experience. Such a dramatic drop in...

    Authors: Simon Schimmack, Ulf Hinz, Andreas Wagner, Thomas Schmidt, Hendrik Strothmann, Markus W Büchler and Hubertus Schmitz-Winnenthal
    Citation: Health Economics Review 2014 4:14
  13. To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of...

    Authors: Hanna Koskinen, Elina Ahola, Leena K Saastamoinen, Hennamari Mikkola and Jaana E Martikainen
    Citation: Health Economics Review 2014 4:9
  14. In Switzerland, age is the predominant driver of solidarity transfers in risk adjustment (RA). Concerns have been voiced regarding growing imbalances in cost sharing between young and old insured due to demogr...

    Authors: Viktor von Wyl and Konstantin Beck
    Citation: Health Economics Review 2014 4:7
  15. While induced abortion is considered to be illegal and socially unacceptable in Nigeria, it is still practiced by many women in the country. Poor family planning and unsafe abortion practices have daunting eff...

    Authors: Bosede O Awoyemi and Jacob Novignon
    Citation: Health Economics Review 2014 4:3
  16. To identify associations between market factors, especially relative reimbursement rates, and the probability of surgery and cost per episode for three medical conditions (cataract, benign prostatic neoplasm, ...

    Authors: Jack Hadley, James D Reschovsky, James A O’Malley and Bruce E Landon
    Citation: Health Economics Review 2014 4:8
  17. In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-t...

    Authors: Dawn C Lee, Daniel Gladwell, Anthony J Hatswell, Joshua Porter, Nic Brereton, Elaine Tate and Alison L Saunders
    Citation: Health Economics Review 2014 4:6
  18. The prospective reimbursement of hospitals through the grouping of patients into a finite number of categories (Diagnosis Related Groups, DRGs), is common to many European countries. However, the specific cate...

    Authors: James Gaughan and Conrad Kobel
    Citation: Health Economics Review 2014 4:4
  19. The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant ...

    Authors: Inna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, Melanie Drechsler, Daniel Kalanovic, Peter Kaskel, Frank Langer, Jörg Ruof, Thorsten Ruppert and Daniel Wirth
    Citation: Health Economics Review 2014 4:2
  20. Care of stroke patients costs considerably more in specialized stroke units (SU) compared to care in general medical wards (GMW) but the technology may be cost effective if it leads to significantly improved o...

    Authors: Farasat AS Bokhari, Ian Wellwood, Anthony G Rudd, Peter Langhorne, Martin S Dennis and Charles DA Wolfe
    Citation: Health Economics Review 2014 4:1
  21. In April 2008, specialization in gynecology and obstetrics departments was introduced in the Sennan area of Osaka prefecture in Japan that aimed at solving the problems of regional provisions of obstetrics ser...

    Authors: Yoshimi Adachi, Hiroyasu Iso, Junyi Shen, Kanami Ban, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Kenichiro Morishige and Tatuyoshi Saijo
    Citation: Health Economics Review 2013 3:31
  22. Patient-centered health care and shared decision making are of increasing importance in the management of AIDS/HIV patients and require an intensive consideration of patient preferences. The present study asse...

    Authors: Axel C Mühlbacher, Matthias Stoll, Jörg Mahlich and Matthias Nübling
    Citation: Health Economics Review 2013 3:30
  23. Recently the sequencing of the human genome has become a major biological and clinical research field. However, the public health impact of this new technology with focus on the financial effect is not yet to ...

    Authors: Martin Frank, Anne Prenzler, Roland Eils and J-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2013 3:29
  24. The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including...

    Authors: Carlos Crespo, Estela Moreno, Jordi Sierra, Suzan Serip and Marta Rubio
    Citation: Health Economics Review 2013 3:28
  25. Rotavirus gastroenteritis (RVGE) is a frequent disease in young children. The recommended German paediatric immunisation schedule does not currently include rotavirus vaccination. A lack of economic data on th...

    Authors: Stefanie Knoll, Christoph Mair, Ursula Benter, Katja Vouk and Baudouin Standaert
    Citation: Health Economics Review 2013 3:27

Annual Journal Metrics

  • 2022 Citation Impact
    2.4 - 2-year Impact Factor
    2.8 - 5-year Impact Factor
    1.204 - SNIP (Source Normalized Impact per Paper)
    0.836 - SJR (SCImago Journal Rank)

    2023 Speed
    11 days submission to first editorial decision for all manuscripts (Median)
    220 days submission to accept (Median)

    2023 Usage 
    566,888 downloads
    483 Altmetric mentions